Bal Pharma Ltd.

BSE: 524824 | NSE: BALPHARMA |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE083D01012 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Bal Pharma Ltd Bal Pharma Ltd. | BSE 72.33 -1.26 (-1.71%) | NSE 72.68 -0.34 (-0.47%) | Trade | Add

BSE Live

Jan 02, 15:08

72.33 -1.26 (-1.71%)

Volume

AVERAGE VOLUME

5-Day

4,268

10-Day

2,306

30-Day

1,771

238

Prev. Close

73.59
Open Price

73.01

Bid Price (Qty.)
72.41 (142)
Offer Price (Qty.)
73.55 (4)

NSE Live

Jan 02, 15:08

72.68 -0.34 (-0.47%)

Volume

AVERAGE VOLUME

5-Day

8,619

10-Day

6,517

30-Day

7,954

2,802

Prev. Close

73.02
Open Price

71.25

Bid Price (Qty.)
72.70 (100)
Offer Price (Qty.)
73.99 (68)

Financials

Print/Copy to Excel : Go

Balance Sheet of Bal Pharma (in Rs. Cr.)	Mar 15	Mar 14	Mar 11	Mar 10	Mar 09
	12 mths	12 mths	12 mths	12 mths	12 mths
EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	12.87	11.11	10.48	10.48	10.48
Total Share Capital	12.87	11.11	10.48	10.48	10.48
Reserves and Surplus	40.31	37.20	25.69	25.28	26.75
Total Reserves and Surplus	40.31	37.20	25.69	25.28	26.75
Total Shareholders Funds	55.20	50.05	36.18	35.76	37.23
Minority Interest	-0.03	0.00	0.00	0.00	0.00
NON-CURRENT LIABILITIES
Long Term Borrowings	6.64	7.97	57.73	21.22	22.23
Deferred Tax Liabilities [Net]	7.29	8.24	6.81	6.24	5.79
Other Long Term Liabilities	0.75	0.66	0.00	0.00	0.00
Long Term Provisions	1.65	1.06	0.00	0.00	0.00
Total Non-Current Liabilities	16.34	17.92	64.54	27.46	28.02
CURRENT LIABILITIES
Short Term Borrowings	40.14	42.75	0.00	33.20	24.94
Trade Payables	38.53	33.53	0.00	17.17	16.42
Other Current Liabilities	11.86	8.66	33.06	9.79	12.57
Short Term Provisions	1.83	1.83	1.53	0.82	2.36
Total Current Liabilities	92.36	86.77	34.59	60.98	56.28
Total Capital And Liabilities	163.86	154.74	135.30	124.20	121.54
ASSETS
NON-CURRENT ASSETS
Tangible Assets	47.32	50.31	48.32	49.75	54.93
Intangible Assets	4.87	4.87	5.94	5.23	4.94
Capital Work-In-Progress	0.77	0.25	0.13	0.00	0.40
Fixed Assets	52.97	55.42	54.39	54.98	60.27
Non-Current Investments	0.02	0.02	0.02	0.02	0.02
Deferred Tax Assets [Net]	0.00	0.00	0.00	0.00	0.00
Long Term Loans And Advances	5.43	3.96	0.00	0.00	0.00
Other Non-Current Assets	0.33	0.22	0.00	0.00	0.00
Total Non-Current Assets	58.74	59.63	54.40	55.00	60.28
CURRENT ASSETS
Current Investments	0.00	0.00	0.00	0.00	0.00
Inventories	35.82	31.71	32.21	28.62	23.89
Trade Receivables	44.98	45.49	37.02	31.92	29.29
Cash And Cash Equivalents	5.49	3.02	2.23	1.61	1.36
Short Term Loans And Advances	18.63	14.76	9.44	7.05	6.72
OtherCurrentAssets	0.20	0.13	0.00	0.00	0.00
Total Current Assets	105.12	95.12	80.90	69.20	61.25
Total Assets	163.86	154.74	135.30	124.20	121.54
OTHER ADDITIONAL INFORMATION
CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	20.90	18.50	12.32	0.00	0.14
BONUS DETAILS
Bonus Equity Share Capital	3.04	3.04	3.04	3.04	3.04
NON-CURRENT INVESTMENTS
Non-Current Investments Quoted Market Value	0.00	0.00	0.00	0.00	0.00
Non-Current Investments Unquoted Book Value	0.02	0.02	0.02	0.02	0.02
CURRENT INVESTMENTS
Current Investments Quoted Market Value	0.00	0.00	0.00	0.00	0.00
Current Investments Unquoted Book Value	0.00	0.00	0.00	0.00	0.00